BONOMINI, Mario
 Distribuzione geografica
Continente #
NA - Nord America 5.926
EU - Europa 5.708
AS - Asia 2.566
Continente sconosciuto - Info sul continente non disponibili 14
SA - Sud America 6
AF - Africa 5
OC - Oceania 3
Totale 14.228
Nazione #
US - Stati Uniti d'America 5.895
CN - Cina 1.203
UA - Ucraina 1.131
IE - Irlanda 1.114
IT - Italia 904
TR - Turchia 823
SE - Svezia 722
GB - Regno Unito 577
FR - Francia 406
DE - Germania 378
IN - India 267
FI - Finlandia 210
SG - Singapore 173
RU - Federazione Russa 169
VN - Vietnam 55
CZ - Repubblica Ceca 40
CA - Canada 28
BE - Belgio 20
EU - Europa 14
IR - Iran 13
PL - Polonia 12
HK - Hong Kong 11
IL - Israele 9
NL - Olanda 7
TW - Taiwan 6
BR - Brasile 5
ES - Italia 3
AT - Austria 2
AU - Australia 2
DK - Danimarca 2
EG - Egitto 2
GR - Grecia 2
MK - Macedonia 2
PA - Panama 2
RO - Romania 2
TN - Tunisia 2
BD - Bangladesh 1
CH - Svizzera 1
EC - Ecuador 1
HR - Croazia 1
JP - Giappone 1
KR - Corea 1
LV - Lettonia 1
MU - Mauritius 1
MX - Messico 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PK - Pakistan 1
SM - San Marino 1
Totale 14.228
Città #
Jacksonville 1.274
Dublin 1.101
Chandler 1.069
Princeton 517
Southend 450
Izmir 417
Nanjing 354
Houston 339
Ashburn 337
Wilmington 275
Dearborn 219
Cambridge 209
Chieti 185
Beijing 163
Altamura 145
Nanchang 143
Ann Arbor 130
Woodbridge 98
Singapore 93
New York 79
Boardman 78
Shenyang 77
Hebei 68
Washington 57
Dong Ket 55
Jiaxing 54
Tianjin 54
Kunming 50
Jinan 35
Brno 32
Norwalk 32
Hangzhou 29
Vittuone 29
Ningbo 28
Changsha 26
Grevenbroich 23
Rome 23
Zhengzhou 21
Brussels 20
Leawood 20
Augusta 19
Los Angeles 19
Bari 18
Pescara 18
Düsseldorf 17
Kocaeli 17
San Mateo 17
Seattle 17
Hefei 16
Helsinki 16
Ottawa 16
Orange 15
Lanzhou 14
Taizhou 13
Ardabil 12
Milan 12
Guangzhou 11
Hong Kong 11
Kraków 11
Falls Church 10
Taranto 10
Ferrara 9
Martinsicuro 9
Changchun 8
Auburn Hills 7
Fuzhou 7
Munich 7
Naples 7
Olomouc 7
Pune 7
Simi Valley 7
Toronto 7
Cedar Knolls 6
London 6
Moscow 6
Vellore 6
Bangalore 5
Frankfurt am Main 5
Omegna 5
Shanghai 5
Catania 4
Cepagatti 4
Chicago 4
Hanover 4
Muzzana del Turgnano 4
Paris 4
Perugia 4
Redmond 4
San Vito Chietino 4
Trani 4
Walnut 4
Xian 4
Andover 3
Bologna 3
Brugnera 3
Buccinasco 3
Carmiano 3
Fermo 3
Guardiagrele 3
Iseo 3
Totale 8.915
Nome #
[Erythrocyte abnormalities and their possible role in cardiovascular complications of uremia] 377
Therapy of glucocorticoid induced osteoporosis 169
Epatotossicità acuta da amiodarone endovena in una paziente in emodialisi 127
Prognostic value of morphologic and morphometric analyses in IgA nephropathy biopsies 117
Adherence of Uremic Erythrocytes to Vascular Endothelium decreases Endothelial Nitric Oxide Synthase Expression 114
Platelet-leukocyte interactions in hemodialysis patients: culprit or bystander? 112
Effect of an L-carnitine-containing peritoneal dialysate on insulin sensitivity in patients treated with CAPD: a 4-month, prospective, multicenter randomized trial. 111
Cell activation and cellular-cellular interactions during hemodialysis: effect of dialyzer membrane 109
Plasma protein carbonylation in chronic uremia 108
Nephrotoxicity induced by chemotherapy [Nefrotossicita' da chemioterapici] 105
Valutazione dell'utilità del test al Captopril nella diagnostica dell'ipertensione renovascolare (IRV) 103
Angiodysplasia of the small bowel: a possible cause of anemia even in mild chronic renal failure 102
Proteomic analysis of protein adsorption capacity of different haemodialysis membranes 102
Calcimimetic R-568 vasodilatory effect effect on mesenteric vascular beds from normotensive (WKY) and spontaneously hypertensive (SHR) rats. Potential involvement of vascular smooth muscle cells (vSMCs) 102
Calcium Sensing Receptor Expression in Ovine Amniotic Fluid Mesenchymal Stem Cells and the Potential Role of R-568 during Osteogenic Differentiation 100
Proteomics characterization of protein adsorption onto hemodialysis membranes 98
Proteomic investigations on the effect of different membrane materials on blood protein adsorption during haemodialysis 97
Mechanisms of uremic erytrocyte-induced adhesion of human monocytes to cultured endothelial cells 96
null 96
Emodiafiltrazione (HDF) con polisulfone (PSF) e neuropatia periferica: una valida alternativa al trattamento emodialitico tradizionale RDT) 95
Adsorption and carbonylation of plasma proteins by dialyser membrane material: in vitro and in vivo proteomics investigations 95
L-carnitine inhibits a subset of platelet activation responses in chronic uraemia 94
Effect of erythropoietin on primed leucocyte expression profile. 93
Elettrofisiologia del sistema nervoso centrale e periferico in pazienti in trattamento sostitutivo: effetti della RDT e della CAPD 92
Thyroid function and plasma selenium in chronic uremic patients onhemodialysis treatment 92
Phylogenetic relationships, biofilm formation, motility, antibiotic resistance and extended virulence genotypes among Escherichia coli strains from women with community-onset primitive acute pyelonephritis 91
A new polymethylmethacrylate membrane for hemodialysis 91
Proteomic Investigations into Hemodialysis Therapy 90
On-line HFR and removal of uremic toxins inducing the loss of phospholipidic asymmetry of the erythrocyte membrane [HFR on-line e rimozione di tossine uremiche inducenti la perdita dell'asimmetria fosfolipidica della membrana eritrocitaria.] 89
Beta2-microglobulin causes abnormal phosphatidylserine exposure in human red blood cells. 89
Uremic toxicity and anemia 87
Effect of peritoneal dialysis fluid containing osmo-metabolic agents on human endothelial cells 87
Quali soluzioni future per la dialisi peritoneale? 87
Examining hemodialyzer membrane performance using proteomic technologies 86
Calcium Sensing Receptor activation by calcimimetic R-568 in human amniotic fluid mesenchymal stem cells: Correlation with osteogenic differentiation. 85
Update sull'impiego della proteomica in emodialisi 85
Platelet activation markers in patients with nephrotic syndrome: A comparative study of different platelet function tests 84
Use of oral hypoglycemic agents in patients with chronic kidney failure 84
Biocompatibility and functional performance of a polyethylene glycol acid-grafted cellulosic membrane for hemodialysis 84
Nitric oxide synthetic pathway and cGMP levels are altered in red blood cells from end-stage renal disease patients 84
Emodiafiltrazione (HDF) con membrane in polisulfone (PSF) ed eritropoietina ricombinante umana (r-HuEPO): si puo' fare di meglio? 83
Metabolic Syndrome in Survivors from the 2009 Earthquake in Italy 82
L-Carnitine is an osmotic agent suitable for peritoneal dialysis 82
Biocompatibility of DIAPES 81
Removal of uremic plasma factors using different dialysis modalities 81
Wireless capsule endoscopy in the diagnostic of small intestine angiodysplasia in chronic uremic patient 81
Emodiafiltrazione con polisulfone: effetti elettrofisiologici sulla neuropatia uremica 81
In vitro microbiology studies on a new peritoneal dialysis connector 81
Defining the potential antidepressant mode of action of acetyl-l-carnitine. 81
Calcimimetic R-568 and its enantiomer s-568 increase nitric oxide release in human endothelial cells 81
Effetto ipolipemizzante della simvastatina nei pazienti in CAPD con ipercolesterolemia 79
null 79
Dislipidemia e progressione della insufficienza renale cronica 78
Terapia ipolipemizzante nella insufficienza renale cronica 78
Vascular inflammation in end-stage renal disease: the red blood cell connection 78
Extra-hepatic manifestations associated with Hepatitis and virus infection 78
Alterazioni del trasporto di Na+ e Ca++ in sinaptosomi di encefalo di ratto uremico: vi è correlazione con la trasmissione sinaptica? 77
Acetylcholine and acetylcarnitine transport in peritoneum: Role of the SLC22A4 (OCTN1) transporter 77
Prevalence and associated variables of postdialysis fatigue: results of a prospective multicenter study 77
Identification of trimethylamine N-oxide (TMAO)-producer phenotype is interesting, but is it helpful? 77
Carnitine in metabolic disease: potential for pharmacological intervention 76
Thyroid function and selenium supplementation in dialytic patients affected by chronic renal failure 76
L-carnitine in uremic anemia 76
Urinary Peptidomic Biomarkers in Kidney Diseases 76
Miglioramento dell'attivita' elettrica cerebrale in pazienti uremici in trattamento emodialitico (RDT) dopo eritropoietina umana ricombinante (r-HuEPO) 75
Glomerulopathies associated with psoriasis: a report of three cases 75
null 74
Enhanced adherence of human uremic erythrocytes to vascular endothelium: role of phosphatidylserine exposure 74
New treatment approaches for the anemia of CKD 74
Carnitine palmitoyltransferase as a potential target for treating diabetes: is inhibition or activation preferable? 74
Toward personalized hemodialysis by low molecular weight amino-containing compounds: future perspective of patient metabolic fingerprint 74
Biocompatibility assessment of haemodialysis membrane materials by proteomic investigations 73
Blood cell proteomics in chronic kidney disease 73
L-Carnitine status in end-stage renal disease patients on automated peritoneal dialysis 73
Leukocyte adhesion molecules and leukocyte-platelet interactions during hemodialysis: effects of different synthetic membranes 72
Recovery time after hemodialysis is inversely associated with the ultrafiltration rate. 72
Selenium in uremia 71
Alterazioni ematologiche nelle malattie renali e alterazioni renali in corso di malattie ematologiche 71
Sjogren’s syndrome associated with haemolytic-uraemic syndrome as presenting clinical manifestation: a case report 71
Current opinion on usage of L-carnitine in end-stage renal disease patients on peritoneal dialysis 71
Effects of L-carnitine administration on erythrocyte survival in haemodialysis patients 68
Increased erythrocyte phosphatidylserine exposure in chronic renal failure 68
Red blood cells may contribute to hypercoagulability in uraemia via enhanced surface exposure of phosphatidylserine 68
Erythropoietin induces miRNA-210 by JAK2/STAT5 signaling in PBMCs of End-stage Renal Disease patients 68
Effects of selenium supplementation on immune parameters in chronic uraemic patients on haemodialysis 68
Watch out for lumbosciatalgy 68
Lipidi ed uremia 67
Phenotypic characterization of kidney infiltrating cell subsets in idiopathic acute interstitial nephritis associated with uveitis: evidence for a cell-mediated immune disease 67
Effetto protettivo dei Ca++-antagonisti (CCB) sulla nefrotossicità da ciclosporina (CyA) 67
Endoscopy as a tool for diagnosing and treating gastrointestinal angiodysplasia in haemodialysis patients 67
Management of IgA nephropathy 67
Proteomic analysis of protein adsorption onto haemodialysis membranes 67
Dialysis practice and patient outcome in the aftermath of the earthquake at L'Aquila, Italy, April 2009 67
Prevalence and severity of postdialysis fatigue are higher in patients on chronic hemodialysis with functional disability 66
Variazioni elettrofisiologiche cerebrali indotte dal trattamento con eritropoietina ricombinante umana (r-HuEPO) in pazienti in trattamento emodialitico convenzionale (RDT) 65
Hemodynamic-guided therapy in essential hypertension: a new pathophysiological approach 65
Calcimimetic R-568 and its enantiomer induce a rapid, reversible, and only partially endothelium-mediated vasodilation in perfused mesenteric arteries from normotensive and spontaneously hypertensive rats 65
Severa neutropenia durante trattamento con amoxicillina/acido clavulanico in un paziente in trattamento emodialitico regolare [Severe neutropenia during treatment with amoxicillin/clavulanic acid in a patient on regular hemodialysis treatment] 65
Cell-associated adhesion molecules as early markers of bioincompatibility 64
Low-Dosage Ibopamine Treatment in Progressive Renal Failure: A Long-Term Multicentre Trial 64
Totale 8.603
Categoria #
all - tutte 57.363
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.363


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.299 0 244 68 181 274 187 356 275 123 300 262 29
2020/20211.803 247 15 247 44 156 333 15 95 152 272 98 129
2021/20221.147 66 28 30 205 79 22 25 74 102 42 145 329
2022/20233.210 339 386 149 325 286 627 238 226 435 30 94 75
2023/20241.795 112 46 115 58 114 616 388 75 14 37 25 195
2024/2025263 247 16 0 0 0 0 0 0 0 0 0 0
Totale 15.602